Reader Comments

Year : 2020 | Volume:  22 | Issue Number:  1

INVITED RESEARCH HIGHLIGHT

Darolutamide: a novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer

Aragon-Ching Jeanny B

Add Your Comments
 
No one has added comments on this article. Click here to add your remarks


 

Feedback
Back To Article
Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal